United States · FDA National Drug Code directory
Rasuvo
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59137-550_29d04017-dd64-4dea-a064-7b3b0805f423
- Product NDC
- 59137-550
- Form
- INJECTION, SOLUTION
- Composition / generic term
- methotrexate
- Labeler
- Medexus Pharma Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20140710
- Source listing expiry
- 20261231
Source-listed ingredients
- METHOTREXATE SODIUM — 30 mg/.6mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 PACKAGE in 1 CARTON (59137-550-01) / .6 mL in 1 PACKAGE (59137-550-00) · 59137-550-01
- 4 PACKAGE in 1 CARTON (59137-550-04) / .6 mL in 1 PACKAGE (59137-550-00) · 59137-550-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →